nach oben

Erschienen in:

2016 | OriginalPaper | Buchkapitel

18. Bedeutung rekombinanter Allergene und Allergenderivate

verfasst von : R. Valenta, Prof. Dr. med., E. Wollmann, Dr. med.

Erschienen in: Allergologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Dieses Kapitel soll einen Überblick über biochemische, biologische und klinische Eigenschaften von Allergenen geben, welche eine wichtige Rolle in der IgE-vermittelten Allergie spielen. Durch die Verwendung rekombinanter DNS-Technologie ist das Wissen im Bereich der Allergencharakterisierung rapide gewachsen. Die strukturellen biochemischen sowie immunologischen Eigenschaften von Allergenen können nun im Detail erforscht werden. Dieses Wissen beeinflusst in grundlegender Weise Diagnostik, Forschung und klinische Anwendung in der Allergologie. Es werden grundlegende Eigenschaften von Allergenen, der Weg von der DNS-Sequenz der Allergene zum rekombinanten Allergen und mögliche Anwendungen rekombinanter Allergene für die Analyse allergischer Erkrankungen, deren Diagnose und Therapie besprochen.

Aichberger KJ, Mittermann I, Reininger R, Seiberler S, Swoboda I, Spitzauer S, Kopp T, Stingl G, Sperr WR, Valent P, Repa A, Bohle B, Kraft D, Valenta R (2005) Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity. J Immunol 175: 1286–1294

Akkerdaas JH, Wensing M, Knulst AC, Krebitz M, Breiteneder H, de Vries S, Penninks AH, Aalberse RC, Hefle SL, van Ree R (2003) How accurate and safe is the diagnosis of hazelnut allergy by means of commercial skin prick test reagents? Int Arch Allergy Immunol 132: 132–140

Andersson K, Lidholm J (2003) Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol 130: 87–107

Arruda LK (2005) Cockroach allergens. Curr Allergy Asthma Rep 5: 411–416

Ball T, Vrtala S, Sperr WR, Valent P, Susani M, Kraft D, Valenta R (1994) Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. Dissection of the allergic effector reaction. J Biol Chem 269: 28323–28328

Ball T, Sperr WR, Valent P, Lidholm J, Spitzauer S, Ebner C, Kraft D, Valenta R (1999) Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol 29: 2026–2036

Banerjee S, Weber M, Blatt K, Swoboda I, Focke-Tejkl M, Valent P, Valenta R, Vrtala S (2014) Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine. J Immunol 192: 4867–4875

Bessot JC, Pauli G (2011) Mite allergens: an overview. Eur Ann Allergy Clin Immunol 43: 141–156

Bhalla PL, Swoboda I, Singh MB (1999) Antisense-mediated silencing of a gene encoding a major ryegrass pollen allergen. Proc Natl Acad Sci U S A 96: 11676–11680

Birkner T, Rumpold H, Jarolim E, Ebner H, Breitenbach M, Skvaril F, Scheiner O, Kraft D (1990) Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 45: 418–426

Bohle B, Zwolfer B, Heratizadeh A, Jahn-Schmid B, Antonia YD, Alter M, Keller W, Zuidmeer L, van Ree R, Werfel T, Ebner C (2006) Cooking birch pollen-related food: divergent consequences for IgE- and T cell-mediated reactivity in vitro and in vivo. J Allergy Clin Immunol 118: 242–249

Bolhaar ST, Tiemessen MM, Zuidmeer L, van Leeuwen A, Hoffmann-Sommergruber K, Bruijnzeel-Koomen CA, Taams LS, Knol EF, van Hoffen E, van Ree R, Knulst AC (2004) Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy 34: 761–769

Breiteneder H, Ferreira F, Hoffmann-Sommergruber K, Ebner C, Breitenbach M, Rumpold H, Kraft D, Scheiner O (1993) Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties. Eur J Biochem 212: 355–362

Bugajska-Schretter A, Elfman L, Fuchs T, Kapiotis S, Rumpold H, Valenta R, Spitzauer S (1998) Parvalbumin, a cross-reactive fish allergen, contains IgE-binding epitopes sensitive to periodate treatment and Ca2+ depletion. J Allergy Clin Immunol 101: 67–74

Burks AW (2004) Food Allergens. In: Lockey RF, Bukantz SC, Bousquet J (Hrsg) Allergens and Allergen Immunotherapy. Marcel Dekker, New York

Campana R, Mothes N, Rauter I, Vrtala S, Reininger R, Focke-Tejkl M, Lupinek C, Balic N, Spitzauer S, Valenta R (2008) Non-IgE-mediated chronic allergic skin inflammation revealed with rBet v 1 fragments. J Allergy Clin Immunol 121: 528–530 e1

Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, Melioli G, Nunes C, Passalacqua G, Rosenwasser L, Sampson H, Sastre J, Bousquet J, Zuberbier T (2013) A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 6: 17

Casset A, Mari A, Purohit A, Resch Y, Weghofer M, Ferrara R, Thomas WR, Alessandri C, Chen KW, de Blay F, Valenta R, Vrtala S (2012) Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol 159: 253–262

Caubet JC, Sampson HA (2012) Beyond skin testing: state of the art and new horizons in food allergy diagnostic testing. Immunol Allergy Clin North Am 32: 97–109

Chapman MD, Pomes A, Breiteneder H, Ferreira F (2007) Nomenclature and structural biology of allergens. J Allergy Clin Immunol 119: 414–420

Colombo P, Bonura A, Costa M, Izzo V, Passantino R, Locorotondo G, Amoroso S, Geraci D (2003) The allergens of Parietaria. Int Arch Allergy Immunol 130: 173–179

Corinti S, de Palma RD, Fontana A, Gagliardi MC, Pini C, Sallusto F (1997) Major histocompatibility complex-independent recognition of a distinctive pollen antigen, most likely a carbohydrate, by human CD8+ alpha/beta T cells. J Exp Med 186: 899–908

Diaz-Sanchez D, Dotson AR, Takenaka H, Saxon A (1994) Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest: 94: 1417–1425

Diaz-Sanchez D, Tsien A, Fleming J, Saxon A (1997) Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol 158: 2406–2413

Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S (2006) Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117: 802–809

Earle CD, King EM, Tsay A, Pittman K, Saric B, Vailes L, Godbout R, Oliver KG, Chapman MD (2007) High-throughput fluorescent multiplex array for indoor allergen exposure assessment. J Allergy Clin Immunol 119: 428–433

Esch RE (2004) Grass pollen allergens. Clin Allergy Immunol 18: 185–205

Fernandez-Caldas E, Puerta L, Caraballo L, Lockey RF (2004) Mite Allergens. In: Lockey RF, Bukantz SC, Bousquet J (Hrsg) Allergens and Allergen Immunotherapy. Marcel Dekker, New York

Ferreira F, Hirtenlehner K, Jilek A, Godnik-Cvar J, Breiteneder H, Grimm R, Hoffmann-Sommergruber K, Scheiner O, Kraft D, Breitenbach M, Rheinberger HJ, Ebner C (1996) Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 183: 599–609

Ferreira F, Wallner M, Gadermaier G, Erler A, Fritz G, Glatter O, Himly M, Briza P, van Ree R, Consortium ATC (2005) Regulatory Control and Standardization of Allergenic Extracts. Chmielorz, Wiesbaden

Fischer J, Hebsaker J, Caponetto P, Platts-Mills TA, Biedermann T (2014) Galactose-alpha-1,3-galactose sensitization is a prerequisite for pork-kidney allergy and cofactor-related mammalian meat anaphylaxis. J Allergy Clin Immunol 134: 755–759 e1

Flicker S, Valenta R (2003) Renaissance of the blocking antibody concept in type I allergy. Int Arch Allergy Immunol 132: 13–24

Flicker S, Steinberger P, Ball T, Krauth MT, Verdino P, Valent P, Almo S, Valenta R (2006) Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. J Allergy Clin Immunol 117: 1336–1343

Focke M, Marth K, Valenta R (2009) Molecular composition and biological activity of commercial birch pollen allergen extracts. Eur J Clin Invest 39: 429–436

Focke-Tejkl M, Weber M, Niespodziana K, Neubauer A, Huber H, Henning R, Stegfellner G, Maderegger B, Hauer M, Stolz F, Niederberger V, Marth K, Eckl-Dorna J, Weiss R, Thalhamer J, Blatt K, Valent P, Valenta R (2014) Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol 135: 1207–1217

Gadermaier G, Dedic A, Obermeyer G, Frank S, Himly M, Ferreira F (2004) Biology of weed pollen allergens. Curr Allergy Asthma Rep 4: 391–400

Gieras A, Focke-Tejkl M, Ball T, Verdino P, Hartl A, Thalhamer J, Valenta R (2007) Molecular determinants of allergen-induced effector cell degranulation. J Allergy Clin Immunol 119: 384–390

Gilissen LJ, Bolhaar ST, Matos CI, Rouwendal GJ, Boone MJ, Krens FA, Zuidmeer L, van Leeuwen A, Akkerdaas J, Hoffmann-Sommergruber K, Knulst AC, Bosch D, Van de Weg WE, van Ree R (2005) Silencing the major apple allergen Mal d 1 by using the RNA interference approach. J Allergy Clin Immunol 115: 364–369

Grote M, Vrtala S, Niederberger V, Valenta R, Reichelt R (2000) Expulsion of allergen-containing materials from hydrated rye grass (Lolium perenne) pollen revealed by using immunogold field emission scanning and transmission electron microscopy. J Allergy Clin Immunol 105: 1140–1145

Grote M, Valenta R, Reichelt R (2003) Abortive pollen germination: a mechanism of allergen release in birch, alder, and hazel revealed by immunogold electron microscopy. J Allergy Clin Immunol 111: 1017–1023

van Hage-Hamsten M, Pauli G (2004) Provocation testing with recombinant allergens. Methods 32: 281–291

Harwanegg C, Laffer S, Hiller R, Mueller MW, Kraft D, Spitzauer S, Valenta R (2003) Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy 33: 7–13

Haselden BM, Kay AB, Larche M (1999) Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 189: 1885–1894

Heiss S, Mahler V, Steiner R, Spitzauer S, Schweiger C, Kraft D, Valenta R (1999) Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing. Invest Dermatol 113: 830–837

Helm RM, Pomes A (2004) Cockroach and other inhalant insect allergens. In: Lockey RF, Bukantz SC, Bousquet J (Hrsg) Allergens and Allergen Immunotherapy. Marcel Dekker, New York

Helm RM, Cockrell G, Connaughton C, Sampson HA, Bannon GA, Beilinson V, Nielsen NC, Burks AW (2000) A soybean G2 glycinin allergen. 2. Epitope mapping and three-dimensional modeling. Int Arch Allergy Immunol 123: 213–219

Herre J, Gronlund H, Brooks H, Hopkins L, Waggoner L, Murton B, Gangloff M, Opaleye O, Chilvers ER, Fitzgerald K, Gay N, Monie T, Bryant C (2013) Allergens as immunomodulatory proteins: the cat dander protein Fel d 1 enhances TLR activation by lipid ligands. J Immunol 191: 1529–1535

Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, Barletta B, Becker WM, Blaser K, Breiteneder H, Chapman M, Crameri R, Duchene M, Ferreira F, Fiebig H, Hoffmann-Sommergruber K, King TP, Kleber-Janke T, Kurup VP, Lehrer SB, Lidholm J, Muller U, Pini C, Reese G, Scheiner O, Scheynius A, Shen HD, Spitzauer S, Suck R, Swoboda I, Thomas W, Tinghino R, Van Hage-Hamsten M, Virtanen T, Kraft D, Muller MW, Valenta R (2002) Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 16: 414–416

Hjelmroos M, Schumacher MJ, Van Hage-Hamsten M (1995) Heterogeneity of pollen proteins within individual Betula pendula trees. Int Arch Allergy Immunol 108: 368–376

Hochwallner H, Schulmeister U, Swoboda I, Spitzauer S, Valenta R (2014) Cow’s milk allergy: from allergens to new forms of diagnosis, therapy and prevention. Methods 66: 22–33

Hoffman DR (2004) Biting insect allergens. In: Lockey RF, Bukantz SC, Bousquet J (Hrsg) Allergens and Allergen Immunotherapy. Marcel Dekker, New York

Hsieh LS, Moos M JR, Lin Y (1995) Characterization of apple 18 and 31 kd allergens by microsequencing and evaluation of their content during storage and ripening. J Allergy Clin Immunol 96: 960–970

Jalil-Colome J, de Andrade AD, Birnbaum J, Casanova D, Mege JL, Lanteaume A, Charpin D, Vervloet D (1996) Sex difference in Fel d 1 allergen production. J Allergy Clin Immunol 98: 165–168

Jarvinen KM, Chatchatee P, Bardina L, Beyer K, Sampson HA (2001) IgE and IgG binding epitopes on alpha-lactalbumin and beta-lactoglobulin in cow’s milk allergy. Int Arch Allergy Immunol 126: 111–118

Kaul S, Luttkopf D, Kastner B, Vogel L, Holtz G, Vieths S, Hoffmann A (2007) Mediator release assays based on human or murine immunoglobulin E in allergen standardization. Clin Exp Allergy 37: 141–150

Kazemi-Shirazi L, Pauli G, Purohit A, Spitzauer S, Froschl R, Hoffmann-Sommergruber K, Breiteneder H, Scheiner O, Kraft D, Valenta R (2000) Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol 105: 116–125

Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R (2002) Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 127: 259–268

King TP, Guralnick M (2004) Hymenoptera allergens. In: Lockey RF, Bukantz SC, Bousquet J (Hrsg) Allergens and Allergen Immunotherapy. Marcel Dekker, New York

King TP, Spangfort MD (2000) Structure and biology of stinging insect venom allergens. Int Arch Allergy Immunol 123: 99–106

Knox RB, Suphioglu C, Taylor P, Desai R, Watson HC, Peng JL, Bursill LA (1997) Major grass pollen allergen Lol p 1 binds to diesel exhaust particles: implications for asthma and air pollution. Clin Exp Allergy 27: 246–251

Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U (1999) Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 103: 1173–1179

Larche M, Akdis CA, Valenta R (2006) Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6: 761–771

Le LQ, Mahler V, Lorenz Y, Scheurer S, Biemelt S, Vieths S, Sonnewald U (2006) Reduced allergenicity of tomato fruits harvested from Lyc e 1-silenced transgenic tomato plants. J Allergy Clin Immunol 118: 1176–1183

Lidholm J, Ballmer-Weber BK, Mari A, Vieths S (2006) Component-resolved diagnostics in food allergy. Curr Opin Allergy Clin Immunol 6: 234–240

Lin KL, Hsieh KH, Thomas WR, Chiang BL, Chua KY (1994) Characterization of Der p V allergen, cDNA analysis, and IgE-mediated reactivity to the recombinant protein. J Allergy Clin Immunol 94: 989–996

Linhart B, Valenta R (2005) Molecular design of allergy vaccines. Curr Opin Immunol 17: 646–655

Lundberg M, Chen Z, Rihs HP, Wrangsjö K (2001) Recombinant spiked allergen extract. Allergy 56: 794–795

Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, Broecker BM, Bublin M, Curin M, Flicker S, Garmatiuk T, Hochwallner H, Mittermann I, Pahr S, Resch Y, Roux KH, Srinivasan B, Stentzel S, Vrtala S, Willison LN, Wickman M, Lødrup-Carlsen KC, Antó JM, Bousquet J, Bachert C, Ebner D, Schlederer T, Harwanegg C, Valenta R (2014) Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods 66: 106–119

Lynch NR, Thomas WR, Garcia NM, Di Prisco MC, Puccio FA, L’opez RI, Hazell LA, Shen HD, Lin KL, Chua KY (1997) Biological activity of recombinant Der p 2, Der p 5 and Der p 7 allergens of the house-dust mite Dermatophagoides pteronyssinus. Int Arch Allergy Immunol 114: 59–67

Mari A (2002) IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int Arch Allergy Immunol 129: 286–295

Mari A (2005) Importance of databases in experimental and clinical allergology. Int Arch Allergy Immunol 138: 88–96

Marsh DG, Goodfriend, King TP, Lowenstein H, Platts-Mills TA (1986) Allergen nomenclature. Bull World Health Organ 64: 767–774

Marth K, Focke M, Flicker S, Valenta R (2004) Human monoclonal antibody-based quantification of group 2 grass pollen allergens. J Allergy Clin Immunol 113: 470–474

Marth K, Wollmann E, Gallerano D, Ndlovu P, Makupe I, Valenta R, Sibanda E (2014) Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS. PLoS One 9(6): e97893

Martinez J, Gutierrez A, Postigo I, Cardona G, Guisantes J (2006) Variability of Alt a 1 expression by different strains of Alternaria alternata. J Investig Allergol Clin Immunol 16: 279–282

Midoro-Horiuti T, Brooks EG, Goldblum RM (2001) Pathogenesis-related proteins of plants as allergens. Ann Allergy Asthma Immunol 87: 261–271

Mittermann I, Swoboda I, Pierson E, Eller N, Kraft D, Valenta R, Heberle-Bors E (1995) Molecular cloning and characterization of profilin from tobacco (Nicotiana tabacum): increased profilin expression during pollen maturation. Plant Mol Biol 27: 137–146

Mohapatra SS, Lockey RF, Polo F (2004) Weed pollen allergens. In: Lockey RF, Bukantz SC, Bousquet J (Hrsg) Allergens and Allergen Immunotherapy. Marcel Dekker, New York

Mothes N, Heinzkill M, Drachenberg KJ, Sperr WR, Krauth MT, Majlesi Y, Semper H, Valent P, Niederberger V, Kraft D, Valenta R (2003) Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 33: 1198–1208

Mothes N, Horak F, Valenta R (2004) Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy. Int Arch Allergy Immunol 135: 357–373

Mothes N, Niggemann B, Jenneck C, Hagemann T, Weidinger S, Bieber T, Valenta R, Novak N (2005) The cradle of IgE autoreactivity in atopic eczema lies in early infancy. J Allergy Clin Immunol 116: 706–709

Motta AC, Marliere M, Peltre G, Sterenberg PA, Lacroix G (2006) Traffic-related air pollutants induce the release of allergen-containing cytoplasmic granules from grass pollen. Int Arch Allergy Immunol 139: 294–298

Moverare R, Westritschnig K, Svensson M, Hayek B, Bende M, Pauli G, Sorva R, Haahtela T, Valenta R, Elfman L (2002) Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol 128: 325–335

Nagpal S, Metcalfe DD, Rao PV (1987) Identification of a shrimp-derived allergen as tRNA. J Immunol 138: 4169–4174

van Neerven RJ, Wikborg T, Lund G, Jacobsen B, Brinch-Nielsen A, Arnved J, Ipsen H (1999) Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 163: 2944–2952

van Neerven RJ, Arvidsson M, Ipsen H, Sparholt SH, Rak S, Wurtzen PA (2004) A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation. Clin Exp Allergy 34: 420–428

van Neerven RJ, Knol EF, Ejrnaes A, Wurtzen PA (2006) IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy. Int Arch Allergy Immunol 141: 119–129

Niederberger V, Laffer S, Froschl R, Kraft D, Rumpold H, Kapiotis S, Valenta R, Spitzauer S (1998a) IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol 101: 258–264

Niederberger V, Pauli G, Gronlund H, Froschl R, Rumpold H, Kraft D, Valenta R, Spitzauer S (1998b) Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations. J Allergy Clin Immunol 102: 579–591

Niederberger V, Stubner P, Spitzauer S, Kraft D, Valenta R, Ehrenberger K, Horak F (2001) Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J Invest Dermatol 117: 848–851

Niederberger V, Niggemann B, Kraft D, Spitzauer S, Valenta R (2002a) Evolution of IgM, IgE and IgG(1-4 )antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms. Eur J Immunol 32: 576–584

Niederberger V, Purohit A, Oster JP, Spitzauer S, Valenta R, Pauli G (2002b) The allergen profile of ash (Fraxinus excelsior) pollen: cross-reactivity with allergens from various plant species. Clin Exp Allergy 32: 933–941

Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth MT, Valent P, Reisinger J, Pelzmann M, Hayek B, Kronqvist M, Gafvelin G, Grönlund H, Purohit A, Suck R, Fiebig H, Cromwell O, Pauli G, van Hage-Hamsten M, Valenta R (2004) Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A 101 Suppl 2: 14677–14682

Niederberger V, Ring J, Rakoski J, Jager S, Spitzauer S, Valent P, Horak F, Kundi M, Valenta R (2007) Antigens drive memory IgE responses in human allergy via the nasal mucosa. Int Arch Allergy Immunol, 142, 133–144

Nilsson OB, van Hage M, Gronlund H (2014) Mammalian-derived respiratory allergens - implications for diagnosis and therapy of individuals allergic to furry animals. Methods 66: 86–95

Panzner P, Vachova M, Vitovcova P, Brodska P, Vlas T (2014) A comprehensive analysis of middle-European molecular sensitization profiles. Int Arch Allergy Immunol 164: 74–82

Pauli G (2000) Evolution in the understanding of cross-reactivities of respiratory allergens: the role of recombinant allergens. Int Arch Allergy Immunol 123: 183–195

Peng Z, Simons FE (2004) Mosquito allergy: immune mechanisms and recombinant salivary allergens. Int Arch Allergy Immunol 133: 198–209

Pirquet C von (1906) Allergie. Muenchner Med Wschr 53: 1457–1458

Purohit A, Laffer S, Metz-Favre C, Verot A, Kricek F, Valenta R, Pauli G (2005) Poor association between allergen-specific serum immunoglobulin E levels, skin sensitivity and basophil degranulation: a study with recombinant birch pollen allergen Bet v 1 and an immunoglobulin E detection system measuring immunoglobulin E capable of binding to Fc epsilon RI. Clin Exp Allergy 35: 186–192

Purohit A, Niederberger V, Kronqvist M, Horak F, Grönneberg R, Suck R, Weber B, Fiebig H, van Hage M, Pauli G, Valenta R, Cromwell O (2008) Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy 38: 1514–1525

Reisinger J, Triendl A, Küchler E, Bohle B, Krauth MT, Rauter I, Valent P, Koenig F, Valenta R, Niederberger V (2005a) IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation. J Allergy Clin Immunol 115: 973–981

Reisinger J, Horak F, Pauli G, Van Hage M, Cromwell O, Konig F, Valenta R, Niederberger V (2005b) Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol 116: 347–354

Rossi RE, Monasterolo G, Coco G, Silvestro L, Operti D (2007) Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Vaccine 25: 957–964

Roux KH, Teuber SS, Sathe SK (2003) Tree nut allergens. Int Arch Allergy Immunol 131: 234–244

Salazar F, Sewell HF, Shakib F, Ghaemmaghami AM (2013) The role of lectins in allergic sensitization and allergic disease. J Allergy Clin Immunol 132: 27–36

Sancho AI, Rigby NM, Zuidmeer L, Asero R, Mistrello G, Amato S, Gonzalez-Mancebo E, Fernandez-Rivas M, Van Ree R, Mills EN (2005) The effect of thermal processing on the IgE reactivity of the non-specific lipid transfer protein from apple, Mal d 3. Allergy 60: 1262–1268

Sastre J (2010) Molecular diagnosis in allergy. Clin Exp Allergy 40: 1442–1460

Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosigno MV, Mahillo I (2012) How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy 67: 709–711

Savolainen J, Viander M, Einarsson R, Koivikko A (1989) Allergenic variability of different strains of Candida albicans. Int Arch Allergy Appl Immunol 90: 61–66

Schappi GF, Suphioglu C, Taylor PE, Knox RB (1997) Concentrations of the major birch tree allergen Bet v 1 in pollen and respirable fine particles in the atmosphere. J Allergy Clin Immunol 100: 656–661

Schimek EM, Zwolfer B, Briza P, Jahn-Schmid B, Vogel L, Vieths S, Ebner C, Bohle B (2005) Gastrointestinal digestion of Bet v 1-homologous food allergens destroys their mediator-releasing, but not T cell-activating, capacity. J Allergy Clin Immunol 116: 1327–1333

Schmid-Grendelmeier P, Crameri R (2001) Recombinant allergens for skin testing. Int Arch Allergy Immunol 125: 96–111

Scholl I, Jensen-Jarolim E (2004) Allergenic potency of spices: hot, medium hot, or very hot. Int Arch Allergy Immunol 135: 247–261

Shreffler WG, Beyer K, Chu TH, Burks AW, Sampson HA (2004) Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol 113: 776–782

Slater JE (2004) Latex allergens. In: Lockey RF, Bukantz SC, Bousquet J (Hrsg) Allergens and Allergen Immunotherapy. Marcel Dekker, New York

Spertini F, Perrin Y, Audran R, Pellaton C, Boudousquie C, Barbier N, Thierry AC, Charlon V, Reymond C (2014) Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. J Allergy Clin Immunol 134: 239–240 e13

Spök A, Gaugitsch H, Laffer S, Pauli G, Saito H, Sampson H, Sibanda E, Thomas W, Van Hage M, Valenta R (2005) Suggestions for the assessment of the allergenic potential of genetically modified organisms. Int Arch Allergy Immunol 137: 167–180

Suphioglu C (2000) What are the important allergens in grass pollen that are linked to human allergic disease? Clin Exp Allergy 30: 1335–1341

Suphioglu C, Singh MB, Taylor P, Bellomo R, Holmes P, Puy R, Knox RB (1992) Mechanism of grass-pollen-induced asthma. Lancet 339: 569–572

Tada Y, Nakase M, Adachi T, Nakamura R, Shimada H, Takahashi M, Fujimura T, Matsuda T (1996) Reduction of 14-16 kDa allergenic proteins in transgenic rice plants by antisense gene. FEBS Lett 391: 341–345

Tashpulatov AS, Clement P, Akimcheva SA, Belogradova KA, Barinova I, Rakhmawaty FD, Heberle-Bors E, Touraev A (2004) A model system to study the environment-dependent expression of the Bet v 1a gene encoding the major birch pollen allergen. Int Arch Allergy Immunol 134: 1–9

Taylor PE, Flagan RC, Valenta R, Glovsky MM (2002) Release of allergens as respirable aerosols: A link between grass pollen and asthma. J Allergy Clin Immunol 109: 51–56

Traidl-Hoffmann C, Mariani V, Hochrein H, Karg K, Wagner H, Ring J, Mueller MJ, Jakob T, Behrendt H (2005) Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 201: 627–636

Trivedi B, Valerio C, Slater JE (2003) Endotoxin content of standardized allergen vaccines. J Allergy Clin Immunol 111: 777–783

Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, Thorne PS, Wills-Karp M, Gioannini TL, Weiss JP, Karp CL (2009) Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457: 585–588

Twaroch TE, Curin M, Valenta R, Swoboda I (2014) Mold allergens in respiratory allergy: from structure to therapy. Allergy Asthma Immunol Res 7: 205–220

Valent P, Hauswirth AW, Natter S, Sperr WR, Buhring HJ, Valenta R (2004) Assays for measuring in vitro basophil activation induced by recombinant allergens. Methods 32: 265–270

Valenta R (2002) The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2: 446–453

Valenta R, Kraft D (2001) Recombinant allergen molecules: tools to study effector cell activation. Immunol Rev 179: 119–127

Valenta R, Kraft D (2002) From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 14: 718–727

Valenta R, Kraft D (2004) Recombinant allergens: from production and characterization to diagnosis, treatment, and prevention of allergy. Methods 32: 207–208

Valenta R, Niederberger V (2007) Recombinant allergens for immunotherapy. J Allergy Clin Immunol 119: 826–830

Valenta R, Duchene M, Pettenburger K, Sillaber C, Valent P, Bettelheim P, Breitenbach M, Rumpold H, Kraft D, Scheiner O (1991) Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science 253: 557–560

Valenta R, Duchene M, Ebner C, Valent P, Sillaber C, Deviller P, Ferreira F, Tejkl M, Edelmann H, Kraft D et al. (1992) Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 175: 377–385

Valenta R, Steinberger P, Duchene M, Kraft D (1996) Immunological and structural similarities among allergens: prerequisite for a specific and component-based therapy of allergy. Immunol Cell Biol 74: 187–194

Valenta R, Flicker S, Eibensteiner PB, Steinberger P, Laffer S, Dolecek C, Kraft D (1997) Recombinant allergen-specific antibody fragments: tools for diagnosis, prevention and therapy of type I allergy. Biol Chem 378: 745–749

Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H (1999) The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 29: 896–904

Valenta R, Ball T, Focke M, Linhart B, Mothes N, Niederberger V, Spitzauer S, Swoboda I, Vrtala S, Westritschnig K, Kraft D (2004) Immunotherapy of allergic disease. Adv Immunol 82: 105–153

Valenta R, Campana R, Marth K, Van Hage M (2012) Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med 272: 144–157

Valenta R, Hochwallner H, Linhart B, Pahr S (2015) Food Allergies: The Basics. Gastroenterology 148: 1120–1131

Valerio CR, Murray P, Arlian LG, Slater JE (2005) Bacterial 16S ribosomal DNA in house dust mite cultures. J Allergy Clin Immunol 116: 1296–1300

Vassilopoulou E, Rigby N, Moreno FJ, Zuidmeer L, Akkerdaas J, Tassios I, Papadopoulos NG, Saxoni-Papageorgiou P, van Ree R, Mills C (2006) Effect of in vitro gastric and duodenal digestion on the allergenicity of grape lipid transfer protein. J Allergy Clin Immunol 118: 473–480

van der Veen MJ, Mulder M, Witteman AM, van Ree R, Aalberse RC, Jansen HM, van der Zee JS (1996) False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens. J Allergy Clin Immunol 98: 1028–1034

Villalba M, Rodriguez R, Batanero E (2014) The spectrum of olive pollen allergens. From structures to diagnosis and treatment. Methods 66: 44–54

Vrtala S, Grote M, Duchene M, van Ree R, Kraft D, Scheiner O, Valenta R (1993) Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity. Int Arch Allergy Immunol 102: 160–169

Vrtala S, Ball T, Spitzauer S, Pandjaitan B, Suphioglu C, Knox B, Sperr WR, Valent P, Kraft D, Valenta R (1998) Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J Immunol 160: 6137–6144

Vrtala S, Huber H, Thomas WR (2014) Recombinant house dust mite allergens. Methods 66: 67–74

Wachholz PA, Soni NK, Till SJ, Durham SR (2003) Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 112: 915–922

Wagner S, Breiteneder H (2005) Hevea brasiliensis latex allergens: current panel and clinical relevance. Int Arch Allergy Immunol 136: 90–97

Wal JM (2001) Structure and function of milk allergens. Allergy 56 Suppl 67: 35–58

Weghofer M, Grote M, Resch Y, Casset A, Kneidinger M, Kopec J, Thomas WR, Fernández-Caldas E, Kabesch M, Ferrara R, Mari A, Purohit A, Pauli G, Horak F, Keller W, Valent P, Valenta R, Vrtala S (2013) Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol 190: 3059–3067

Westritschnig K, Sibanda E, Thomas W, Auer H, Aspock H, Pittner G, Vrtala S, Spitzauer S, Kraft D, Valenta R (2003) Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy 33: 22–27

Willison LN, Sathe SK, Sroux KH (2014) Production and analysis of recombinant tree nut allergens. Methods 66: 34–43

Wollmann E, Lupinek C, Kundi M, Selb R, Niederberger V, Valenta R (2015) Reduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy, J Allergy Clin Immunol pii: S0091-6749(15)00340

Wopfner N, Gadermaier G, Egger M, Asero R, Ebner C, Jahn-Schmid B, Ferreira F (2005) The spectrum of allergens in ragweed and mugwort pollen. Int Arch Allergy Immunol 138: 337–346

Wu LC, Zarrin AA (2014) The production and regulation of IgE by the immune system. Nat Rev Immunol 14: 247–259

Titel: Bedeutung rekombinanter Allergene und Allergenderivate
verfasst von: R. Valenta, Prof. Dr. med.
E. Wollmann, Dr. med.
Verlag: Springer Berlin Heidelberg
Buch: Allergologie
Print ISBN: 978-3-642-37202-5

Electronic ISBN: 978-3-642-37203-2

Copyright-Jahr: 2016
DOI: https://doi.org/10.1007/978-3-642-37203-2_18

Neu im Fachgebiet HNO

16.04.2024 | HNO-Chirurgie | Nachrichten

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

18. Bedeutung rekombinanter Allergene und Allergenderivate

Zusammenfassung

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO